Envoy Medical, Inc. (COCH)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Medical Products	225.00K	316.00K	237.00K	310.00K
Medical Products Growth	-28.80%	33.33%	-23.55%	-
Total	225.00K	316.00K	237.00K	310.00K
Total Growth	-28.80%	33.33%	-23.55%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	225.00K	316.00K	237.00K	310.00K
United States Growth	-28.80%	33.33%	-23.55%	-
Total	225.00K	316.00K	237.00K	310.00K
Total Growth	-28.80%	33.33%	-23.55%	-

Source: S&P Global Market Intelligence.